Pan et al. showed that Interleukin-35 (IL-35) improved acute lung injury through suppressing inflammatory response by blocking the activation of NF-κB pathway in a LPS-induced mice ALI model [6]. Here, NFKB1 is linked to acute respiratory distress syndrome.